Macao

Reimbursed Care Access

Macau maintains a strict statutory control regime for narcotics and psychotropic substances under Lei n.º 17/2009 (with multiple later amendments). Common classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, ibogaine, ayahuasca constituents, 2C‑X) are listed under the drug control tables or otherwise fall under the broad prohibitions in the anti‑drug law and have no authorized medical reimbursement pathways outside approved research. Ketamine is explicitly controlled but is listed for clinical/medical use (normally as an anaesthetic) under Macau’s drug schedules; there is no publicly available evidence of a reimbursed, licensed psychiatric esketamine (Spravato) program in Macau as of the latest Macau Boletim Oficial updates. [https://bo.io.gov.mo/bo/i/2023/47/lei18.asp|Boletim Oficial — Lei n.º 18/2023] [https://bo.dsaj.gov.mo/bo/i/2025/25/lei02.asp|Boletim Oficial — Lei n.º 2/2025].